Lukas Ronner
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 1
- Neurology top 5%
- Oncology top 10%
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Hemoglobinopathies and Related Disorders 3
-
- Acute Myeloid Leukemia Research 2
-
- Eosinophilic Disorders and Syndromes 2
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
-
- Skin and Cellular Biology Research 1
-
- Diversity and Career in Medicine 1
- Co-authors
- Pratik SinhaMatthew TaylorRachel PinottiCarolyn S. CalfeeMatthieu LegrandCameron J. TurtleMichael O. HarhayClifford S. Deutschman
- Partner nations
- United States
In The Last Decade
Lukas Ronner
12 papers receiving 846 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Infectious Diseases 395
- Neurology 245
- Critical Care and Intensive Care Medicine 52
- Oncology 270
- Immunology 159
Countries citing papers authored by Lukas Ronner
This map shows the geographic impact of Lukas Ronner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Ronner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Ronner more than expected).
Fields of papers citing papers by Lukas Ronner
This network shows the impact of papers produced by Lukas Ronner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Ronner. The network helps show where Lukas Ronner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lukas Ronner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2022 | 12 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 5 | |
| 6 | Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromesbreakdown → | 2020 | 551 |
| 7 | 2020 | 12 | |
| 8 | 2019 | 2 | |
| 9 | 2019 | 11 | |
| 10 | 2016 | 9 | |
| 11 | 2015 | 235 | |
| 12 | 2014 | 12 |
About Lukas Ronner
Lukas Ronner is a scholar working on Genetics, Otorhinolaryngology and Hematology, having authored 12 papers that have together received 856 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Hemoglobinopathies and Related Disorders (3 papers), Acute Myeloid Leukemia Research (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Skin and Cellular Biology Research (1 paper) and Diversity and Career in Medicine (1 paper). The work is most often cited by research in Infectious Diseases (395 citations), Neurology (245 citations) and Critical Care and Intensive Care Medicine (52 citations). Lukas Ronner has collaborated with scholars based in United States. Frequent co-authors include Pratik Sinha, Matthew Taylor, Rachel Pinotti, Carolyn S. Calfee, Matthieu Legrand, Cameron J. Turtle, Michael O. Harhay, Clifford S. Deutschman, Alexandre V. Hirayama and Daniel E. Leisman. Their work appears in journals such as Blood, HemaSphere, The Lancet Respiratory Medicine, Leukemia Research and Academic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.